KRAS status and efficacy in the first-line treatment of patients with metastatic colorectal cancer (mCRC) treated with FOLFIRI with or without cetuximab: The CRYSTAL experience - Van Cutsem, E; Lang, I; D’haens, G (J Clin Oncol, 2008)
(abstr 2)